SAB Biotherapeutics, Inc. (SABS)

NASDAQ

$3.07

$+0.04

(+1.42%)

Pre-Market

SAB Biotherapeutics, Inc. (SABS) Live Price Chart

Last updated: ⁦2026-10-07 10:52:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

SAB Biotherapeutics, Inc. (SABS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.07, with a market capitalization of $282.06M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.10 to $5.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$282.06M
Open	$3.03
Day's High	$120.90
Day's Low	$1.00
Previous Close	$2.93
Volume	128.00
Average Volume	486.88K
P/E Ratio	--
52-Week High	$5.15
52-Week Low	$2.10
Dividend Yield	--
Earnings Date	--

SAB Biotherapeutics, Inc. (SABS) Pre-Market Stock Price

SAB Biotherapeutics, Inc. (SABS) is trading at $3.07 in pre-market trading as of 2026-10-07 09:36:00, up 4.91% ($0.14) from the previous close of $2.93

Pre-market trading shows how investors are pricing SABS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

SAB Biotherapeutics, Inc. (SABS) 7-Day Stock Price Change

Over the past seven days, SAB Biotherapeutics, Inc. (SABS) moved from $3.22 to $3.07, representing a decline of 4.39% ($0.14).

The stock traded between $2.86 and $3.40 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 660.01 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

SABS 52-Week Price Position

Position in Range: 31.9%

52W Low$2.10

52W High$5.15

SABS is currently trading at $3.07, placing it 31.9% of the way from its 52-week low of $2.10 to its 52-week high of $5.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is SAB Biotherapeutics, Inc. (SABS)?

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

SAB Biotherapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	86
Exchange	NASDAQ
Company Website	https://www.sab.bio

How to Buy SAB Biotherapeutics, Inc. (SABS) Stock on MEXC

Eligible investors can buy real shares of SAB Biotherapeutics, Inc. (SABS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SABS and Place Your Order

Open the RealStocks trading page and search for SABS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is SAB Biotherapeutics, Inc. (SABS) stock price today?

SAB Biotherapeutics, Inc. (SABS) is currently trading at $ 3.07, up 4.91% ($0.14) from the previous close of $ 2.93. Intraday prices update in real time during regular trading hours.

2.Is SABS stock going up or down today?

As of 2026-10-07 09:36:00, SABS is trading at $ 3.07, up 4.91% ($0.14) from its previous close of $ 2.93. The stock has traded between $ 1.00 and $ 120.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is SABS pre-market price?

As of 2026-10-07 09:36:00, SABS is trading at $ 3.07 in pre-market trading, up 4.91% ($0.14) from the previous close of $ 2.93. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SABS after-hours price?

As of 2026-10-07 09:36:00, SABS is trading at $ 3.03 in after-hours trading, up 3.48% ($0.10) from the regular-session close of $ 2.93. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SABS stock trading now?

SABS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SABS sit relative to its 52-week high and low?

Over the past 52 weeks, SABS has traded between a low of $ 2.10 and a high of $ 5.15. At $ 3.07, the stock is positioned 31.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is SAB Biotherapeutics, Inc. in?

SAB Biotherapeutics, Inc. (SABS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is SAB Biotherapeutics, Inc.'s market capitalization and where is it listed?

SAB Biotherapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 282.06M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SABS valued in terms of P/E ratio and EPS?

SABS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does SAB Biotherapeutics, Inc. pay a dividend?

SAB Biotherapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.